Menu

Sex Matters

Researchers reveal a new pathway of synaptic modulation in the hippocampus exclusive to females.

Oct 1, 2012
Kerry Grens

EDITOR'S CHOICE IN NEUROBIOLOGY

The paper

G.Z. Huang, C.S. Woolley, “Estradiol acutely suppresses inhibition in the hippocampus through a sex-specific endocannabinoid and mGluR-dependent mechanism,” Neuron, 74:801-08, 2012.

The finding

The ovarian reproductive hormone estradiol (E2) is synthesized in the hippocampus of both males and females, where it is thought to affect hippocampal functions such as memory and mood-related behavior by increasing the excitability of neurons. To nail down just how this works, Guang Zhe Huang and Catherine Woolley of Northwestern University recorded electrical signals from rat hippocampal slices exposed to E2. They found that, in addition to its excitatory effects, E2 suppresses inhibitory synaptic transmission—as if E2 not only steps on the gas to activate neurons, but disables the brakes as well. The team also found that this pathway occurs only in females.

The surprise

E2 acts on inhibitory neurons by enlisting compounds called endocannabinoids. Surprisingly, the research team found that the endocannabinoid involved was different than the one that had been observed in previous studies of hippocampal signaling. The reason for this disparity, they realized, was that they had used female rats, while earlier work had used male rats.

The implications

Paul Mermelstein of the University of Minnesota points out that the vast majority of basic neuroscience experiments are done in male animals. “There may be a whole infrastructure in terms of endocannabinoid signaling present in the female brain that’s not present in males,” he says.

The next steps

Woolley would like to find out how these sex differences in synaptic modulation affect the functioning of the hippocampus. One possibility she’s exploring if E2 is important in regulating epileptic seizures; another is whether E2-endocannabinoid signaling is involved in anxiety.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!